Eloxx Pharmaceuticals Statistics
NASDAQ: ELOXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
10.69-0.19 (-1.75%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Eloxx Pharmaceuticals by the numbers
Eloxx Pharmaceuticals has a market capitalization of $43.7 million based on 4.09M shares outstanding. Its trailing P/E ratio is 5.6. The stock trades 23.8% below its 50-day average and 25.7% below its 200-day average.
Average daily trading volume is 28.48K shares, or about $304,398 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ELOX valuation vs. peer median
| Metric | ELOX | Peer median | Difference |
|---|---|---|---|
| Market cap | $43.69M | $46.57M | -6% |
| Avg. volume | 28.48K | 164.29K | -83% |
Peer median across 8 companies: GRML, INKT, ELUT, IMA, TIL, AVXL, CGTX, OKYO.
Valuation
- Market cap
- $43.69M
- P/E (TTM)
- 5.63
- EPS (TTM)
- $1.90
- Shares outstanding
- 4.09M
Price and trading
- Previous close
- 10.88
- Open
- 10.65
- Day range
- 10.03 – 10.94
- 52-week range
- 8.20 – 23.40
- Beta
- —
- Volume
- 14.98K
- Average volume
- 28.48K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Apr 2, 2025
Additional statistics
- Market Cap
- 43.69M
- Pe
- 5.63
- Forward Pe
- -2.99
- Eps
- 1.90
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.40
- Week52 Low
- 8.20
- Avg Volume
- 28,475.00
- Shares Outstanding
- 4.09M
- Ma50
- 14.02
- Ma200
- 14.39
- Earnings Date
- Apr 2, 2025
- Pct From52w High
- -54.32%
- Pct From52w Low
- 30.37%